Natalia Fernandez

Employment

• IAVI Senior Scientist
  2024 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (3)

• Safety and immunogenicity of a recombinant vesicular stomatitis virus-based Sudan virus vaccine in adults in the USA: a single-blind, first-in-human, dose-escalation phase 1 clinical trial
  The Lancet Microbe 2026 DOI: 10.1016/j.lanmic.2026.101492
  +Save
• Safety and immunogenicity of the ChAdOx1–MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK
  The Lancet Microbe 2025 DOI: 10.1016/j.lanmic.2024.100956
  +Save
• Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes
  Vaccines 2023 DOI: 10.3390/vaccines11020472
  +Save